Figure 3From: Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2Celecoxib effects the in vivo tumor growth of Lewis lung carcinoma cells. Dose dependent delay of tumor growth with celecoxib in mice regardless of irradiation.Back to article page